No current committee memberships matched for this official.
Intent: To secure Designated Centre status for Nua Healthcare's Gormanston facility.
Details: To brief about efforts regarding obtaining Designated Centre status at Gormanston Approved Centre (LSU) and related efforts to achieve clarity on the regulatory process surrounding same.
Intent: Reimbursement of Friedriech's ataxia drug Skyclarys
Details: Letter to HSE leadership re reimbursement of Skyclarys for people living with Freidriech's ataxia
Intent: Attendance at upcoming Associated EU Presidency on Rare Diseases on Nov 13
Details: Invitation to attend RDI's associated EU Presidency Event
Intent: Support for AsIAm's HSE-funded services, accessible healthcare for Autistic people and the expansion of our services across the country
Details: Met with the CEO of the HSE to discuss the work of AsIAm and our strategic ambitions
Intent: In light of the current volatility, on the island of Ireland, we now request an immediate focus on protection of healthcare workers attending work and leaving work, particularly in our larger cities and in border regions.
Details: Racially Motivated Incidents in Northern Ireland
Intent: Thank CEO for attending ADC and addressing delegates. Seek meeting for further engagement on issues relating to nurses and midwives.
Details: INMO ADC 2026
Intent: Sought to ensure the HSE's new Autism Protocol was appropriately resourced, met the needs of the Autistic community and was not seen as a substitute for the statutory right to assessment of need
Details: Engaged with public officials on the HSE's proposed new Autism protocol
Intent: To take account of,and consider adopting, IPHA proposals to increase the number of clinical trials being conducted in Ireland.
Details: Number of Clinical Trials in Ireland
Intent: Discuss the practical implementation of the new Framework Agreement and how to address shared challenges to achieve its objectives.
Details: Overview of the IPHA Framework Agreement
Intent: Supporting discussions to ensure Skyclarys (omalexolone) becomes available to patients in Ireland, in line with many European countries
Details: Reimbursement decision for the treatment of Friederich's ataxia
